InfuSystem Holdings (INFU) Amortization of Deferred Charges (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Amortization of Deferred Charges came in at $21000.0 in Q1 2026, up 10.53% YoY from $19000.0 in Q1 2025, and up 5.0% on a QoQ basis from $20000.0 in Q4 2025.
InfuSystem Holdings (INFU) Amortization of Deferred Charges (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 11 years of Amortization of Deferred Charges data on file, last reported at $21000.0 in Q1 2026.
- Quarterly Amortization of Deferred Charges rose 10.53% year-over-year to $21000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $83000.0 (up 6.41% YoY) and the FY2025 annual result came in at $81000.0, up 3.85% from the prior year.
- Amortization of Deferred Charges climbed to $21000.0 in Q1 2026, from $20000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $60000.0 in Q2 2023 to a low of $18000.0 in Q1 2022.
- A 5-year average of $21941.2 and a median of $20000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges tumbled 81.25% — and 2023, when it soared 215.79%.
- Tracing INFU's Amortization of Deferred Charges over 5 years: stood at $18000.0 in 2022, then rose by 16.67% to $21000.0 in 2023, then slipped by 4.76% to $20000.0 in 2024, then changed by 0.0% to $20000.0 in 2025, then gained by 5.0% to $21000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $21000.0 (Q1 2026), $20000.0 (Q4 2025), and $22000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | InfuSystem Holdings | 244.87 Mn | 243.90 Mn | 21.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21,000.00 |
| Jun 30, 2026 | 21,000.00 |
| Mar 31, 2026 | 21,000.00 |
| Mar 31, 2026 | 21,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,000.00 |